B. Conditions-d-'utilisation-et-caractéristiques-du-test-combiné and .. , 76 1 Conditions de conservation des prélèvements, p.76

C. L-'étude, D. Oraquick®, and H. , 81 1 Performance du dépistage de l'hépatite C sur sang capillaire et fluide oral, p.82

D. Lavanchy, E. Couturier, and Y. Strat, Liver Int [2] Département des maladies infectieuses. L'épidémiologie des hépatites B et C en France, Estimation de la séroprévalence du VIH et du VHC et profils des usagers de drogues en France, étude INVS-ANRS Coquelicot, pp.74-81, 2006.

S. Laperche, M. Elghouzzi, P. Morel, M. Asso-bonnet, N. Marrec et al., Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing? Transfusion Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals The emerging pattern of post-transfusion hepatitis, J Clin Microbiol, vol.45, issue.444, pp.1965-1972, 2005.

S. Feinstone, A. Kapikian, R. Purcell, H. Alter, P. Holland et al., Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B, New England Journal of Medicine, vol.292, issue.15, pp.767-770, 1975.
DOI : 10.1056/NEJM197504102921502

M. Houghton, Discovery of the hepatitis C virus, Liver International, vol.29, issue.1, pp.82-88, 2009.
DOI : 10.1111/j.1478-3231.2008.01925.x

A. Cahour, Un nouveau défi pour la recherche sur le virus de l'hépatite C, Virologie, vol.10, pp.159-65, 2006.

S. Chevaliez and J. Pawlotsky, Hepatitis C virus: Virology, diagnosis and management of antiviral therapy, World Journal of Gastroenterology, vol.13, issue.17, pp.2461-2466, 2007.
DOI : 10.3748/wjg.v13.i17.2461

J. Pawlotsky, Le virus de l???h??patite C, m??decine/sciences, vol.18, issue.3, pp.303-317, 2002.
DOI : 10.1051/medsci/2002183303

T. Santantonio, J. Wiegand, and J. Gerlach, Acute hepatitis C: Current status and remaining challenges, Journal of Hepatology, vol.49, issue.4, pp.625-633, 2008.
DOI : 10.1016/j.jhep.2008.07.005

J. Orland, T. Wright, and S. Cooper, Acute hepatitis C, Hepatology, vol.33, issue.2, pp.321-327, 2001.
DOI : 10.1053/jhep.2001.22112

J. Wiegand, K. Deterding, M. Cornberg, and H. Wedemeyer, Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon ??, Journal of Antimicrobial Chemotherapy, vol.62, issue.5, pp.860-865, 2008.
DOI : 10.1093/jac/dkn346

J. Esteban, S. Sauleda, and J. Quer, The changing epidemiology of hepatitis C virus infection in Europe, Journal of Hepatology, vol.48, issue.1, pp.148-162, 2008.
DOI : 10.1016/j.jhep.2007.07.033

P. Marcellin, F. Pequignot, E. Delarocque-astagneau, J. Zarski, N. Ganne et al., Mortality related to chronic hepatitis B and chronic hepatitis C in France: Evidence for the role of HIV coinfection and alcohol consumption, Journal of Hepatology, vol.48, issue.2, pp.200-207, 2008.
DOI : 10.1016/j.jhep.2007.09.010

URL : https://hal.archives-ouvertes.fr/inserm-00324950

N. Afdhal, The natural history of hepatitis C. Semin Liver Dis, pp.3-8, 2004.

B. Bartosch, R. Thimme, H. Blum, and F. Zoulim, Hepatitis C virus-induced hepatocarcinogenesis, Journal of Hepatology, vol.51, issue.4, pp.810-820, 2009.
DOI : 10.1016/j.jhep.2009.05.008

URL : http://doi.org/10.1016/j.jhep.2009.05.008

J. Yang and L. Roberts, Hepatocellular carcinoma: a global view, Nature Reviews Gastroenterology & Hepatology, vol.150, issue.8, pp.448-458, 2010.
DOI : 10.1038/nrgastro.2010.100

T. Awad, K. Thorlund, G. Hauser, D. Stimac, M. Mabrouk et al., Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials, Hepatology, vol.285, issue.1, pp.1176-1184, 2010.
DOI : 10.1002/hep.23504

M. Fried, M. Shiffman, K. Reddy, C. Smith, G. Marinos et al., Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection, New England Journal of Medicine, vol.347, issue.13, pp.975-982, 2002.
DOI : 10.1056/NEJMoa020047

M. Manns, H. Wedemeyer, and M. Cornberg, Treating viral hepatitis C: efficacy, side effects, and complications, Gut, vol.55, issue.9, pp.1350-1359, 2006.
DOI : 10.1136/gut.2005.076646

F. Poordad, Review article: the role of rapid virological response in determining treatment duration for chronic hepatitis C, Alimentary Pharmacology & Therapeutics, vol.46, issue.suppl 1, pp.1251-1267, 2010.
DOI : 10.1111/j.1365-2036.2010.04300.x

D. Ge, J. Fellay, A. Thompson, J. Simon, K. Shianna et al., Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance, Nature, vol.18, issue.7262, pp.399-401, 2009.
DOI : 10.1038/nature08309

D. Thomas, C. Thio, M. Martin, Y. Qi, D. Ge et al., Genetic variation in IL28B and spontaneous clearance of hepatitis C virus, Nature, vol.119, issue.7265, pp.798-801, 2009.
DOI : 10.1038/nature08463

A. Balagopal, D. Thomas, and C. Thio, IL28B and the Control of Hepatitis C Virus Infection, Gastroenterology, vol.139, issue.6, pp.1865-1876, 2010.
DOI : 10.1053/j.gastro.2010.10.004

M. Lagging, G. Askarieh, F. Negro, S. Bibert, J. Söderholm et al., Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms, PLoS ONE, vol.139, issue.2, p.17232, 2011.
DOI : 10.1371/journal.pone.0017232.t003

J. Darling, J. Aerssens, G. Fanning, J. Mchutchison, D. Goldstein et al., Quantitation of pretreatment serum interferon-??-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response, Hepatology, vol.8, issue.1, pp.14-22, 2011.
DOI : 10.1002/hep.24056

J. Fellay, A. Thompson, D. Ge, C. Gumbs, T. Urban et al., ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C, Nature, vol.18, issue.7287, pp.405-408, 2010.
DOI : 10.1038/nature08825

A. Thompson, J. Fellay, K. Patel, H. Tillmann, S. Naggie et al., Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia and Decrease the Need for Ribavirin Dose Reduction, Gastroenterology, vol.139, issue.4, pp.1181-1189, 2010.
DOI : 10.1053/j.gastro.2010.06.016

I. Jacobson, J. Mchutchison, G. Dusheiko, A. Bisceglie, K. Reddy et al., Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection, New England Journal of Medicine, vol.364, issue.25, pp.2405-2416, 2011.
DOI : 10.1056/NEJMoa1012912

F. Poordad, J. Mccone, B. Bacon, S. Bruno, M. Manns et al., Boceprevir for Untreated Chronic HCV Genotype 1 Infection, New England Journal of Medicine, vol.364, issue.13, pp.1195-1206, 2011.
DOI : 10.1056/NEJMoa1010494

URL : https://hal.archives-ouvertes.fr/hal-00867494

J. Pawlotsky, The Results of Phase III Clinical Trials With Telaprevir and Boceprevir Presented at the Liver Meeting 2010: A New Standard of Care for Hepatitis C Virus Genotype 1 Infection, But With Issues Still Pending, Gastroenterology, vol.140, issue.3, pp.746-754, 2011.
DOI : 10.1053/j.gastro.2011.01.028

B. Bacon, S. Gordon, E. Lawitz, P. Marcellin, J. Vierling et al., Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection, New England Journal of Medicine, vol.364, issue.13, pp.1207-1217, 2011.
DOI : 10.1056/NEJMoa1009482

J. Vermehren and C. Sarrazin, New hepatitis C therapies in clinical development, European Journal of Medical Research, vol.16, issue.7, pp.303-314, 2011.
DOI : 10.1093/jac/dkq086

C. Frank, M. Mohamed, G. Strickland, D. Lavanchy, R. Arthur et al., The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt, The Lancet, vol.355, issue.9207, pp.887-891, 2000.
DOI : 10.1016/S0140-6736(99)06527-7

K. Palitzsch, B. Hottenträger, K. Schlottmann, E. Frick, A. Holstege et al., Prevalence of antibodies against hepatitis C virus in the adult German population, European Journal of Gastroenterology & Hepatology, vol.11, issue.11, pp.1215-1220, 1999.
DOI : 10.1097/00042737-199911000-00005

S. Zou, M. Tepper, and S. Saadany, Prediction of Hepatitis C Burden in Canada, Canadian Journal of Gastroenterology, vol.14, issue.7, pp.575-580, 2000.
DOI : 10.1155/2000/642707

M. Law, G. Dore, N. Bath, S. Thompson, N. Crofts et al., Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001, International Journal of Epidemiology, vol.32, issue.5, pp.717-724, 2001.
DOI : 10.1093/ije/dyg101

G. Armstrong, A. Wasley, E. Simard, G. Mcquillan, W. Kuhnert et al., The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002, Annals of Internal Medicine, vol.144, issue.10, pp.705-714, 1999.
DOI : 10.7326/0003-4819-144-10-200605160-00004

C. Shepard, L. Finelli, and M. Alter, Global epidemiology of hepatitis C virus infection, The Lancet Infectious Diseases, vol.5, issue.9, pp.558-567, 2005.
DOI : 10.1016/S1473-3099(05)70216-4

V. Puro, N. Petrosillo, G. Ippolito, M. Aloisi, E. Boumis et al., Occupational hepatitis C virus infection in Italian health care workers. Italian Study Group on Occupational Risk of Bloodborne Infections., American Journal of Public Health, vol.85, issue.9, pp.1272-1275, 1995.
DOI : 10.2105/AJPH.85.9.1272

A. Bruandet and D. , Incidence and risk factors of HCV infections in a cohort of intravenous drug users in the north and east of france, Epidemiol Infect, vol.132, pp.699-708, 2004.

M. Cornberg, H. Razavi, A. Alberti, E. Bernasconi, M. Buti et al., A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel, Liver International, vol.86, issue.(S, pp.30-60, 2011.
DOI : 10.1111/j.1478-3231.2011.02539.x

W. Sievert, I. Altraif, H. Razavi, A. Abdo, E. Ahmed et al., A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt, Liver International, vol.48, issue.20, p.31, 2011.
DOI : 10.1111/j.1478-3231.2011.02540.x

V. Thiers and R. Tuveri, Epidemiologie moléculaire du virus de l'hépatite C. Revue Francaise des laboratoires, Fevrier/mars, vol.320, pp.41-48, 2000.

D. Chao, K. Abe, and M. Nguyen, Systematic review: epidemiology of hepatitis C genotype 6 and its management, Alimentary Pharmacology & Therapeutics, vol.25, issue.Suppl 1, pp.286-296, 2011.
DOI : 10.1111/j.1365-2036.2011.04714.x

C. Payan, F. Roudot-thoraval, P. Marcellin, N. Bled, G. Duverlie et al., Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study, Journal of Viral Hepatitis, vol.76, issue.4, pp.405-413, 2005.
DOI : 10.1046/j.1365-2893.2002.00319.x

URL : https://hal.archives-ouvertes.fr/hal-00405650

J. Pawlotsky, L. Tsakiris, F. Roudot-thoraval, C. Pellet, L. Stuyver et al., Relationship between Hepatitis C Virus Genotypes and Sources of Infection in Patients with Chronic Hepatitis C, Journal of Infectious Diseases, vol.171, issue.6, pp.1607-1610, 1995.
DOI : 10.1093/infdis/171.6.1607

M. Mohamed, M. Abdel-hamid, N. Mikhail, F. Abdel-aziz, A. Medhat et al., Intrafamilial transmission of hepatitis C in Egypt, Hepatology, vol.2, issue.3, pp.683-687, 2005.
DOI : 10.1002/hep.20811

T. Martins, J. Narciso-schiavon, and L. De-lucca-schiavon, Epidemiologia da infec????o pelo v??rus da hepatite C, Revista da Associa????o M??dica Brasileira, vol.57, issue.1, pp.107-112, 2011.
DOI : 10.1590/S0104-42302011000100024

URL : http://doi.org/10.1590/s0104-42302011000100024

J. Perz, G. Armstrong, L. Farrington, Y. Hutin, and B. Bell, The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide, Journal of Hepatology, vol.45, issue.4, pp.529-538, 2006.
DOI : 10.1016/j.jhep.2006.05.013

J. Wong, G. Mcquillan, J. Mchutchison, and T. Poynard, Estimating future hepatitis C morbidity, mortality, and costs in the United States, Am J Public Health, vol.90, issue.10, pp.1562-1569, 2000.

G. Jeanblanc, Recommandations de la Haute autorité de santé (France) pour le depistage biologique des hépatites virales B et C, Bull Epidémiol HebdWeb, vol.1, pp.1-7, 2011.

D. Dhumeaux, Surveillance et prévention des hépatites B et C en France : bilan et perspectives, Bull Epidémiol Hebd, pp.20-21, 2009.

J. Pawlotsky, Use and interpretation of virological tests for hepatitis C, Hepatology, vol.24, issue.S1, pp.65-73, 2002.
DOI : 10.1002/hep.1840360709

M. Montreuil, Simultaneous detection of hepatitis C virus (HCV) core antigen and anti- HCV antibodies improves the early detection of HCV infection, J Clin Microbiol, vol.43, issue.8, pp.3877-3883, 2005.

C. Thio, K. Nolt, J. Astemborski, D. Vlahov, K. Nelson et al., Screening for hepatitis C virus in human immunodeficiency virus-infected individuals, J Clin Microbiol, vol.38, issue.2, pp.575-577, 2000.

A. Lok, D. Chien, Q. Choo, T. Chan, E. Chiu et al., Antibody response to core, envelope and nonstructural hepatitis C virus antigens: Comparison of immunocompetent and immunosuppressed patients, Hepatology, vol.325, issue.3, pp.497-502, 1993.
DOI : 10.1002/hep.1840180305

G. Kuo, Q. Choo, H. Alter, G. Gitnick, A. Redeker et al., An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis, Science, vol.244, issue.4902, pp.362-364, 1989.
DOI : 10.1126/science.2496467

D. Bresters, H. Cuypers, H. Reesink, W. Schaasberg, C. Van-der-poel et al., Enhanced Sensitivity of a Second Generation ELISA for Antibody to Hepatitis C Virus, Vox Sanguinis, vol.81, issue.4, pp.213-217, 1992.
DOI : 10.1111/j.1423-0410.1992.tb01201.x

S. Uyttendaele, H. Claeys, W. Mertens, H. Verhaert, and C. Vermylen, Evaluation of Third-Generation Screening and Confirmatory Assays for HCV Antibodies, Vox Sanguinis, vol.2, issue.2, pp.122-129, 1994.
DOI : 10.1111/j.1423-0410.1994.tb00293.x

S. Galel, D. Strong, G. Tegtmeier, P. Holland, I. Kuramoto et al., Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays, Transfusion, vol.92, issue.11, pp.1507-1513, 2002.
DOI : 10.1046/j.1537-2995.2001.41060751.x

E. Thomson, E. Nastouli, J. Main, P. Karayiannis, J. Eliahoo et al., Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV, AIDS, vol.23, issue.1, pp.89-93, 2009.
DOI : 10.1097/QAD.0b013e32831940a3

F. Ansaldi, B. Bruzzone, G. Testino, M. Bassetti, R. Gasparini et al., Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection, Journal of Viral Hepatitis, vol.52, issue.1, pp.5-10, 2006.
DOI : 10.1046/j.1365-2893.2003.00430.x

S. Chevaliez, Méthodes alternatives au prélèvement sanguin pour le diagnostic de l'infection par le virus de l'hépatite C, Bull Epidémiol HebdWeb, vol.1, pp.1-5, 2011.

B. White, C. Day, H. Thein, A. Doab, A. Bates et al., Acceptability of hepatitis C virus testing methods among injecting drug users, Drug and Alcohol Review, vol.27, issue.6, pp.666-670, 2008.
DOI : 10.1080/09595230801956116

M. Hickman, T. Mcdonald, A. Judd, T. Nichols, V. Hope et al., Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial, Journal of Viral Hepatitis, vol.316, issue.31, pp.250-254, 2008.
DOI : 10.1017/S0950268806006832

J. Parry, K. Perry, and P. Mortimer, SENSITIVE ASSAYS FOR VIRAL ANTIBODIES IN SALIVA: AN ALTERNATIVE TO TESTS ON SERUM, The Lancet, vol.330, issue.8550, pp.72-75, 1987.
DOI : 10.1016/S0140-6736(87)92737-1

T. Thieme, P. Yoshihara, S. Piacentini, and M. Beller, Clinical evaluation of oral fluid samples for diagnosis of viral hepatitis, J Clin Microbiol, vol.30, issue.5, pp.1076-1079, 1992.

S. Cameron and W. Carman, The use of the OraSure?? collection device for hepatitis virus testing in health care settings, Journal of Clinical Virology, vol.34, issue.1, pp.22-28, 2005.
DOI : 10.1016/S1386-6532(05)80006-X

K. Sherman, R. Creager, J. O-'brien, S. Sargent, S. Piacentini et al., The use of oral fluid for hepatitis C antibody screening, Am J Gastroenterol, vol.89, issue.11, pp.2025-2027, 1994.

S. Allwright, F. Bradley, J. Long, J. Barry, L. Thornton et al., Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey, BMJ, vol.321, issue.7253, pp.78-82, 2000.
DOI : 10.1136/bmj.321.7253.78

A. Judd, J. Parry, M. Hickman, T. Mcdonald, L. Jordan et al., Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots, Journal of Medical Virology, vol.64, issue.1, pp.49-55, 2003.
DOI : 10.1002/jmv.10463

V. Gonzalez, E. Martro, C. Folch, A. Esteve, L. Matas et al., Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies, European Journal of Clinical Microbiology & Infectious Diseases, vol.122, issue.Suppl 1, pp.121-126, 2008.
DOI : 10.1007/s10096-007-0408-z

P. Mcintyre, J. Laszlo, K. Appleyard, and G. Ogden, Modified enzyme immunoassay to detect hepatitis C virus antibodies in oral fluid, European Journal of Clinical Microbiology & Infectious Diseases, vol.34, issue.11, pp.882-884, 1996.
DOI : 10.1007/BF01691223

P. Bello, C. Pasquier, P. Gourney, J. Puel, and J. Izopet, Assessment of a hepatitis C virus antibody assay in saliva for epidemiological studies, European Journal of Clinical Microbiology & Infectious Diseases, vol.9, issue.8, pp.570-572, 1998.
DOI : 10.1007/BF01708621

S. Cameron, K. Wilson, T. Good, J. Mcmenamin, B. Mccarron et al., Detection of antibodies against hepatitis C virus in saliva: a marker of viral replication, Journal of Viral Hepatitis, vol.6, issue.2, pp.141-144, 1999.
DOI : 10.1002/(SICI)1096-9071(199606)49:2<132::AID-JMV10>3.0.CO;2-G

G. Van-doornum, A. Lodder, M. Buimer, E. Van-ameijden, and S. Bruisten, Evaluation of hepatitis C antibody testing in saliva specimens collected by two different systems in comparison with HCV antibody and HCV rna in serum, Journal of Medical Virology, vol.35, issue.1, pp.13-20, 2001.
DOI : 10.1002/jmv.1011

D. Lucidarme, A. Decoster, C. Delamare, C. Schmitt, D. Kozlowski et al., An inter-laboratory study of anti-HCV antibody detection in saliva samples], Gastroenterol Clin Biol, vol.27, issue.2, pp.159-162, 2003.

S. Elsana, E. Sikuler, A. Yaari, Y. Shemer-avni, M. Abu-shakra et al., HCV antibodies in saliva and urine, Journal of Medical Virology, vol.44, issue.1, pp.24-27, 1998.
DOI : 10.1002/(SICI)1096-9071(199805)55:1<24::AID-JMV5>3.0.CO;2-Q

L. Cock, V. Hutse, E. Verhaegen, S. Quoilin, H. Vandenberghe et al., Detection of HCV antibodies in oral fluid, Journal of Virological Methods, vol.122, issue.2, pp.179-183, 2004.
DOI : 10.1016/j.jviromet.2004.09.001

M. Moorthy, H. Daniel, G. Kurian, and P. Abraham, An evaluation of saliva as an alternative to plasma for the detection of hepatitis C virus antibodies, Indian J Med Microbiol, vol.26, issue.4, pp.327-332, 2008.

X. Mariette, P. Loiseau, and F. Morinet, Hepatitis C Virus in Saliva, Annals of Internal Medicine, vol.122, issue.7, p.556, 1995.
DOI : 10.7326/0003-4819-122-7-199504010-00021

K. Roy, J. Bagg, B. Mccarron, T. Good, S. Cameron et al., Predominance of HCV type 2a in saliva from intravenous drug users, Journal of Medical Virology, vol.41, issue.4, pp.271-275, 1998.
DOI : 10.1002/(SICI)1096-9071(199804)54:4<271::AID-JMV6>3.0.CO;2-1

P. Fabris, D. Infantolino, M. Biasin, G. Marchelle, E. Venza et al., High prevalence of HCV-RNA in the saliva cell fraction of patients with chronic hepatitis C but no Evidence of HCV transmission among sexual partners, Infection, vol.44, issue.2, pp.86-91, 1999.
DOI : 10.1007/BF02560503

M. Hermida, M. Ferreiro, S. Barral, R. Laredo, A. Castro et al., Detection of HCV RNA in saliva of patients with hepatitis C virus infection by using a highly sensitive test, Journal of Virological Methods, vol.101, issue.1-2, pp.29-35, 2002.
DOI : 10.1016/S0166-0934(01)00417-7

P. Goncalves, C. Cunha, S. Busek, G. Oliveira, R. Ribeiro-rodrigues et al., Detection of hepatitis C virus RNA in saliva samples from patients with seric anti-HCV antibodies, Brazilian Journal of Infectious Diseases, vol.9, issue.1, pp.28-34, 2005.
DOI : 10.1590/S1413-86702005000100006

M. Maticic, M. Poljak, B. Kramar, K. Seme, V. Brinovec et al., Detection of Hepatitis C Virus RNA From Gingival Crevicular Fluid and Its Relation to Virus Presence in Saliva, Journal of Periodontology, vol.72, issue.1, pp.11-16, 2001.
DOI : 10.1902/jop.2001.72.1.11

L. Lins, H. Almeida, L. Vitvisk, T. Carmo, R. Parana et al., Detection of hepatitis C virus RNA in saliva is not related to oral health status or viral load, Journal of Medical Virology, vol.9, issue.2, pp.216-220, 2005.
DOI : 10.1002/jmv.20438

T. Suzuki, K. Omata, T. Satoh, T. Miyasaka, C. Arai et al., Quantitative Detection of Hepatitis C Virus (HCV) RNA in Saliva and Gingival Crevicular Fluid of HCV-Infected Patients, Journal of Clinical Microbiology, vol.43, issue.9, pp.4413-4417, 2005.
DOI : 10.1128/JCM.43.9.4413-4417.2005

T. Liou, T. Chang, K. Young, X. Lin, C. Lin et al., Detection of HCV RNA in saliva, urine, seminal fluid, and ascites, Journal of Medical Virology, vol.8, issue.3, pp.197-202, 1992.
DOI : 10.1002/jmv.1890370309

K. Komiyama, F. Kawamura, Y. Arakawa, H. Mastuo, N. Hayashi et al., Detection of hepatitis C virus (HCV)-RNA in saliva and gastric juice, Adv Exp Med Biol, vol.371, pp.995-997, 1995.

S. Parker, W. Cubitt, and A. Ades, A method for the detection and confirmation of antibodies to hepatitis C virus in dried blood spots, Journal of Virological Methods, vol.68, issue.2, pp.199-205, 1997.
DOI : 10.1016/S0166-0934(97)00127-4

H. Croom, K. Richards, S. Best, B. Francis, E. Johnson et al., Commercial enzyme immunoassay adapted for the detection of antibodies to hepatitis C virus in dried blood spots, Journal of Clinical Virology, vol.36, issue.1, pp.68-71, 2006.
DOI : 10.1016/j.jcv.2005.12.002

E. Tuaillon, A. Mondain, F. Meroueh, L. Ottomani, M. Picot et al., Dried blood spot for hepatitis C virus serology and molecular testing, Hepatology, vol.68, issue.3, pp.752-758, 2010.
DOI : 10.1002/hep.23407

F. Behets, M. Kashamuka, M. Pappaioanou, T. Green, R. Ryder et al., Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire, J Clin Microbiol, vol.30, issue.5, pp.1179-1182, 1992.

K. Abe and N. Konomi, Hepatitis C virus RNA in dried serum spotted onto filter paper is stable at room temperature, J Clin Microbiol, vol.36, issue.10, pp.3070-3072, 1998.

M. Monleau, C. Butel, E. Delaporte, F. Boillot, and M. Peeters, Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping, Journal of Antimicrobial Chemotherapy, vol.65, issue.8, pp.1562-1566, 2010.
DOI : 10.1093/jac/dkq205

E. Laforgerie, B. Boucher, T. Ly, L. Maisoneuve, J. Izopet et al., Sensitivity of 8 CE (European Community)-approved rapid disposable tests for anti-HIV antibody detection during and after seroconversion, Journal of Virological Methods, vol.165, issue.1, pp.105-107, 2010.
DOI : 10.1016/j.jviromet.2009.12.007

J. Pavie, A. Rachline, B. Loze, L. Niedbalski, C. Delaugerre et al., Sensitivity of Five Rapid HIV Tests on Oral Fluid or Finger-Stick Whole Blood: A Real-Time Comparison in a Healthcare Setting, PLoS ONE, vol.4, issue.19, p.11581, 2010.
DOI : 10.1371/journal.pone.0011581.t005

J. Cummiskey, False positive oral fluid rapid HIV tests, 2005.

S. Lee, G. Yearwood, G. Guillon, L. Kurtz, M. Fischl et al., Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection, Journal of Clinical Virology, vol.48, issue.1, pp.15-17, 2010.
DOI : 10.1016/j.jcv.2010.02.018

S. Lee, K. Kardos, E. Schiff, C. Berne, K. Mounzer et al., Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid, Journal of Virological Methods, vol.172, issue.1-2, pp.27-31, 2011.
DOI : 10.1016/j.jviromet.2010.12.009

B. Smith, J. Drobeniuc, M. Bernard, A. Branson, and R. Garfein, Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. The journal of infectious diseases, pp.825-831, 2011.

T. Asselah, P. Marcellin, G. Matthews, S. Pham, M. Hellard et al., New direct-acting antivirals' combination for the treatment of chronic hepatitis C Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C, Liver Int Clin Infect Dis, vol.31523, issue.1, pp.68-77803, 2011.

M. Hickman, T. Mcdonald, A. Judd, T. Nichols, V. Hope et al., Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial, Journal of Viral Hepatitis, vol.316, issue.31, pp.250-254, 2008.
DOI : 10.1017/S0950268806006832

B. White, C. Day, H. Thein, A. Doab, A. Bates et al., Acceptability of hepatitis C virus testing methods among injecting drug users, Drug and Alcohol Review, vol.27, issue.6, pp.666-670, 2008.
DOI : 10.1080/09595230801956116

M. Miedouge, K. Saune, N. Kamar, M. Rieu, L. Rostaing et al., Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV, J Clin Virol Aids, vol.4823, pp.18-2189, 2009.

D. Anderson, S. Crowe, and M. Garcia, Point-of-Care Testing, Current HIV/AIDS Reports, vol.16, issue.Suppl 1, pp.31-37, 2011.
DOI : 10.1007/s11904-010-0067-z

E. Tuaillon, A. Mondain, F. Meroueh, L. Ottomani, M. Picot et al., Dried blood spot for hepatitis C virus serology and molecular testing, Hepatology, vol.68, pp.752-758, 2010.
DOI : 10.1002/hep.23407

M. Bouvier-alias, K. Patel, H. Dahari, S. Beaucourt, P. Larderie et al., Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication, Hepatology, vol.34, issue.1
DOI : 10.1053/jhep.2002.34130

R. Newcombe, Interval estimation for the difference between independent proportions: comparison of eleven methods, Statistics in Medicine, vol.17, issue.8, pp.873-890, 1998.
DOI : 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I

E. Delong, D. Delong, and D. Clarke-pearson, Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach, Biometrics, vol.44, issue.3
DOI : 10.2307/2531595

V. Hope, M. Hickman, S. Ngui, S. Jones, M. Telfer et al., Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots, Journal of Viral Hepatitis, vol.23, issue.1, pp.262-270, 2011.
DOI : 10.1111/j.1365-2893.2010.01297.x

S. Lee, K. Kardos, E. Schiff, C. Berne, K. Mounzer et al., Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid, Journal of Virological Methods, vol.172, issue.1-2, pp.27-31, 2011.
DOI : 10.1016/j.jviromet.2010.12.009

S. Lee, G. Yearwood, G. Guillon, L. Kurtz, M. Fischl et al., Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection, Journal of Clinical Virology, vol.48, issue.1, pp.15-17, 2010.
DOI : 10.1016/j.jcv.2010.02.018

S. Cameron and W. Carman, The use of the OraSure?? collection device for hepatitis virus testing in health care settings, Journal of Clinical Virology, vol.34, issue.1, pp.22-28, 2005.
DOI : 10.1016/S1386-6532(05)80006-X

J. Garcia-costa, P. Romero, V. Soriano, J. Sheldon, and C. Toro, Seroreversion of Hepatitis C Virus (HCV) Antibodies in an HIV???Infected Patient despite Continuous HCV Replication, Clinical Infectious Diseases, vol.48, issue.11
DOI : 10.1086/598993

E. Herrero-martinez, C. Sabin, C. Lee, I. Jones, D. Pillay et al., The effect of highly active antiretroviral therapy for HIV on the anti-HCV specific humoral immune response, Journal of Medical Virology, vol.12, issue.suppl 1, pp.187-193, 2004.
DOI : 10.1002/jmv.10578

K. Titanji, D. Milito, A. Cagigi, A. Thorstensson, R. Grutzmeier et al., Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection, Blood, vol.108, issue.5, pp.1580-1587, 2006.
DOI : 10.1182/blood-2005-11-013383

G. Van-doornum, A. Lodder, M. Buimer, E. Van-ameijden, and S. Bruisten, Evaluation of hepatitis C antibody testing in saliva specimens collected by two different systems in comparison with HCV antibody and HCV rna in serum, Journal of Medical Virology, vol.35, issue.1, pp.13-20, 2001.
DOI : 10.1002/jmv.1011